Teladoc Health, Inc. (TDOC)

TDOC Financials

TDOC Quarterly Income Statement (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Revenue	2.514B	613.845M	642.269M	626.439M	631.900M	629.369M	640.491M	640.508M	642.444M
Cost of Goods Sold	864.577M	289.813M	197.048M	187.179M	190.537M	196.829M	188.928M	179.745M	188.059M
Gross Profit	1.650B	324.032M	445.221M	439.260M	441.363M	432.540M	451.563M	460.763M	454.385M
Gross Profit Margin	52.8%	52.8%	69.3%	70.1%	69.8%	68.7%	70.5%	71.9%	70.7%
Total Operating Expenses	1.841B	372.761M	481.218M	491.222M	495.748M	553.151M	499.778M	505.164M	1.296B
Research & Development	320.121M	67.865M	71.608M	67.572M	113.076M	69.958M	20.701M	108.200M	107.511M
Selling, General & Administrative	1.061B	304.896M	208.126M	221.873M	325.612M	329.652M	327.448M	339.172M	330.260M
Operating Income (EBIT)	-191.073M	-48.729M	-35.997M	-51.962M	-54.385M	-120.611M	-48.215M	-44.401M	-841.148M
Operating Margin	-7.9%	-7.9%	-5.6%	-8.3%	-8.6%	-19.2%	-7.5%	-6.9%	-130.9%
Income Before Tax (EBT)	-185.105M	-60.842M	-33.618M	-50.222M	-40.423M	-111.267M	-48.171M	-32.496M	-833.787M
Interest Income	107.636M	6.490M	38.525M	52.557M	10.064M	12.674M	14.231M	15.326M	13.572M
Interest Expense	19.317M	5.368M	4.950M	4.526M	4.473M	5.765M	6.846M	5.660M	5.648M
Other Income/Expense	5.968M	-12.113M	2.379M	1.740M	13.962M	9.344M	44K	11.905M	7.361M
Net Income	-171.147M	-63.837M	-25.143M	-49.507M	-32.660M	-93.012M	-48.409M	-33.276M	-837.671M
Income Tax Expense	-13.958M	2.995M	-8.475M	-715K	-7.763M	-18.255M	238K	780K	3.884M
Net Profit Margin	-10.4%	-10.4%	-3.9%	-7.9%	-5.2%	-14.8%	-7.6%	-5.2%	-130.4%
EBITDA	57.314M	38.711M	51.110M	-35.182M	2.675M	-8.963M	11.779M	13.391M	16.614M
EBITDA Margin	6.3%	6.3%	8.0%	-5.6%	0.4%	-1.4%	1.8%	2.1%	2.6%
Depreciation & Amortization	233.187M	94.185M	79.778M	10.514M	48.710M	45.975M	53.936M	53.755M	65.805M
EPS Basic	-0.97	-0.36	-0.14	-0.28	-0.19	-0.53	-0.28	-0.20	-4.92
EPS Diluted	-0.97	-0.36	-0.14	-0.28	-0.19	-0.53	-0.28	-0.19	-4.92
Shares Outstanding	179.122M	179.122M	176.222M	175.679M	175.917M	174.154M	172.765M	170.230M	170.230M
Diluted Shares Outstanding	179.122M	179.122M	176.222M	175.679M	175.917M	174.154M	172.765M	171.496M	170.230M

TDOC Annual Income Statement (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2.530B	2.570B	2.602B	2.407B	2.033B	1.094B	553.307M	417.907M
Cost of Goods Sold	771.593M	751.270M	760.031M	743.987M	650.258M	390.829M	184.465M	128.735M
Gross Profit	1.758B	1.818B	1.842B	1.663B	1.382B	703.133M	368.842M	289.172M
Gross Profit Margin	69.5%	70.8%	70.8%	69.1%	68.0%	64.3%	66.7%	69.2%
Total Operating Expenses	2.021B	2.839B	2.091B	15.316B	1.648B	1.210B	449.284M	360.026M
Research & Development	277.922M	307.274M	348.521M	333.629M	311.884M	164.941M	64.644M	54.373M
Selling, General & Administrative	1.085B	1.346B	1.367B	1.301B	1.105B	886.882M	339.068M	265.160M
Operating Income (EBIT)	-262.955M	-1.021B	-248.553M	-13.653B	-265.631M	-506.421M	-80.442M	-70.854M
Operating Margin	-10.4%	-39.7%	-9.6%	-567.3%	-13.1%	-46.3%	-14.5%	-17.0%
Income Before Tax (EBT)	-235.530M	-993.653M	-219.608M	-13.663B	-384.656M	-575.993M	-109.455M	-96.966M
Interest Income	36.770M	57.071M	46.782M	12.674M	776K	—	—	—
Interest Expense	19.714M	23.803M	22.282M	21.944M	81.141M	59.950M	29.355M	26.112M
Other Income/Expense	27.425M	27.233M	28.945M	-10.129M	-119.025M	-69.572M	-29.013M	-26.112M
Net Income	-200.322M	-1.001B	-220.368M	-13.660B	-428.793M	-485.136M	-98.864M	-97.084M
Income Tax Expense	-35.208M	7.592M	760K	-3.812M	44.137M	-90.857M	-10.591M	118K
Net Profit Margin	-7.9%	-39.0%	-8.5%	-567.5%	-21.1%	-44.3%	-17.9%	-23.2%
EBITDA	147.304M	31.723M	43.613M	-7.537M	-31.416M	-354.493M	-34.870M	-30.361M
EBITDA Margin	5.8%	1.2%	1.7%	-0.3%	-1.5%	-32.4%	-6.3%	-7.3%
Depreciation & Amortization	363.120M	240.511M	254.114M	209.929M	207.572M	63.692M	38.952M	35.602M
EPS Basic	-1.14	-5.87	-1.36	-84.60	-2.73	-5.36	-1.38	-1.47
EPS Diluted	-1.14	-5.87	-1.34	-84.60	-2.73	-5.36	-1.38	-1.47
Shares Outstanding	176.222M	170.564M	162.170M	161.457M	156.939M	90.509M	71.845M	65.845M
Diluted Shares Outstanding	176.222M	170.564M	164.578M	161.457M	156.939M	90.509M	71.845M	65.845M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Teladoc Health, Inc.

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Purchase, NY

4,620 employees

www.teladochealth.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Charles Divita

View full financials